Primer: SNP-associated studies and what they can teach us

Nature Clinical Practice Rheumatology

Volumn 4, Issue 4, 2008, Pages 210-217

  Yamada, Ryo ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; AUTOIMMUNE DISEASE; CROHN DISEASE; DNA SEQUENCE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HAPLOTYPE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOME;

GENETIC HETEROGENEITY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); LINKAGE DISEQUILIBRIUM; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RHEUMATIC DISEASES;

EID: 45549093994     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0757     Document Type: Review

References (44)

1. No authors listed (2001) The human genome. Science genome map. Science 291: 1218
2. No authors listed (2001) Everyone's genome. Nature 409: 813
3. The International HapMap Consortium (2003) The International HapMap Project. Nature 426: 789-796
4. Przeworski M et al. (2000) Adjusting the focus on human variation. Trends Genet 16: 296-302
5. Reich DE et al. (2002) Human genome sequence variation and the influence of gene history, mutation and recombination. Nat Genet 32: 135-142
6. Sachidanandam R et al. (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409: 928-933
7. Feuk L et al. (2006) Structural variation in the human genome. Nat Rev Genet 7: 85-97
8. Lupski JR (2007) Structural variation in the human genome. N Engl J Med 356: 1169-1171
9. Aitman TJ et al. (2006) Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439: 851-855
10. Fellermann K et al. (2006) A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet 79: 439-448
11. Sigurdsson S et al. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76: 528-537
12. Graham RR et al. (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38: 550-555
13. Graham RR et al. (2007) Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci USA 104: 6758-6763
14. Bottini N et al. (2004) A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36 337-338
15. Kyogoku C et al. (2002) Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: Contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 46: 1242-1254
16. Floto RA et al. (2005) Loss of function of a lupus-associated FcγRIIb polymorphism through exclusion from lipid rafts. Nat Med 11: 1056-1058
17. Suzuki A et al. (2003) Functional haplotypes of PAD14, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34: 395-402
18. Okamoto K et al (2003) Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet 72: 303-312
19. Tokuhiro S et al. (2003) An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 35: 341-348
20. Swanberg M et al. (2005) MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 37: 486-494
21. Su K et al. (2004) A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcyRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J Immunol 172: 7186-7191
22. Kochi Y et al. (2005) A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autolmmunities. Nat Genet 37: 478-485
23. Maeda N et al. (2006) Transcript annotation in FANTOM & mouse gene catalog based on physical cDNAs. PLoS Genet 2: E62
24. Ozaki K et al. (2002) Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 32: 650-654
25. Zaitlen N et al. (2007) Leveraging the HapMap correlation structure in association studies. Am J Hum Genet 80: 683-691
26. McPherson R et al. (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316: 1488-1491
27. Balding DJ (2006) A tutorial on statistical methods for population association studies. Nat Rev Genet 7: 781-791
28. Klein RJ et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389
29. Duerr RH et al. (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 1461-1463
30. Hampe J et al. (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39: 207-211
31. Smyth DJ et al. (2006) A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 38 617-619
32. Grant SF et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38: 320-323
33. Sladek R et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445: 881-885
34. Glacomini KM et al. (2007) The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther 81: 328-345
35. Tate SK and Goldstein DB (2004) Will tomorrow's medicines work for everyone? Nat Genet 36: S34-S42
36. Goldstein DB et al. (2007) Potential genetic causes of heterogeneity of treatment effects. Am J Med 120: S21-S25
37. Seddon JM et al. (2007) Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 297: 1793-1800
38. Locke DIP et al. (2006) Linkage disequilibrium and heritability of copy-number polymorphisms within duplicated regions of the human genome. Am J Hum Genet 79: 275-290
39. McCarroll SA et al. (2006) Common deletion polymorphisms in the human genome. Nat Genet 38: 86-92
40. Schildkraut JM (1998) Examining complex genetic interactions. In Approaches to Gene Mapping in Complex Human Diseases, 379-410 (Eds Haines JL and Pericak-Vance MA) New York: John Wiley & Sons
41. Begovich AB et al. (2O04) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase ( PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75: 330-337
42. Kyogoku C et al. (2004) Genetic association of the R62OW polymorphism of protein tyrosine phosphatase PTPN22 with hu man SLE. Am J Hum Genet 75: 504-507
43. Remmers EF et al. (2007) STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357 977-986
44. Plenge R M et al. (2007) TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N Engl J Med 357: 1199-1209